VC
TMO icon

Veracity Capital’s Thermo Fisher Scientific TMO Stock Holding History

Veracity Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$296K Buy
438
+32
+8% +$19K 0.08% 178
2026
Q2 		$203K Sell
406
-34
-8% -$16.3K 0.05% 216
2026
Q1 		$216K Sell
440
-513
-54% -$278K 0.08% 191
2025
Q4 		$552K Sell
953
-200
-17% -$113K 0.16% 124
2025
Q3 		$559K Buy
+1,153
New +$537K 0.18% 125
2025
Q2 		– Sell
-436
Closed -$217K – 252
2025
Q1 		$217K Buy
+436
New +$236K 0.08% 212
2024
Q4 		– Sell
-559
Closed -$346K – 234
2024
Q3 		$346K Sell
559
-5
-0.9% -$2.96K 0.13% 152
2024
Q2 		$312K Sell
564
-173
-23% -$99.1K 0.13% 149
2024
Q1 		$428K Buy
737
+123
+20% +$69K 0.17% 135
2023
Q4 		$326K Sell
614
-75
-11% -$36.3K 0.13% 145
2023
Q3 		$349K Buy
689
+8
+1% +$4.26K 0.16% 128
2023
Q2 		$355K Buy
681
+47
+7% +$25.4K 0.15% 142
2023
Q1 		$365K Sell
634
-35
-5% -$19.7K 0.17% 134
2022
Q4 		$369K Sell
669
-30
-4% -$15.9K 0.18% 124
2022
Q3 		$355K Sell
699
-26
-4% -$14.6K 0.19% 116
2022
Q2 		$394K Sell
725
-172
-19% -$94.7K 0.21% 113
2022
Q1 		$530K Sell
897
-923
-51% -$530K 0.22% 105
2021
Q4 		$1.22M Sell
1,820
-310
-15% -$194K 0.49% 51
2021
Q3 		$1.22M Sell
2,130
-202
-9% -$111K 0.52% 48
2021
Q2 		$1.18M Sell
2,332
-216
-8% -$102K 0.27% 80
2021
Q1 		$1.16M Buy
2,548
+132
+5% +$63K 0.53% 49
2020
Q4 		$1.13M Buy
2,416
+1,705
+240% +$799K 0.58% 54
2020
Q3 		$314K Buy
+711
New +$294K 0.18% 143
2020
Q2 		– Sell
-999
Closed -$283K – 254
2020
Q1 		$283K Buy
999
+114
+13% +$35.9K 0.08% 153
2019
Q4 		$287K Buy
+885
New +$268K 0.07% 184

Other funds holding TMO

DLA
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return
QPBE
Quintet Private Bank (Europe) Luxembourg $2.28B AUM 23.89% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.16B AUM 31.35% 1-Year Est. Return
AIM
Avity Investment Management Greenwich, Connecticut $1.6B AUM 32.15% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return

Veracity Capital's TMO Position: Q3 2026 in Review

Veracity Capital increased its Thermo Fisher Scientific (TMO) stake by 7.9% in Q3 2026, buying an estimated $19K and bringing the position to 438 shares worth $296K. The position accounts for 0.08% of the portfolio, ranked #178.

Veracity Capital first reported a position in TMO in Q4 2019 and has held it in 25 quarters since. The position peaked at $1.22M in Q3 2021. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Veracity Capital held 438 shares of Thermo Fisher Scientific worth $296K as of Q3 2026.
  • Veracity Capital bought 32 Thermo Fisher Scientific shares in Q3 2026, an estimated $19K.
  • Thermo Fisher Scientific made up 0.08% of Veracity Capital's portfolio in Q3 2026, its #178 holding.
  • Veracity Capital first reported a position in Thermo Fisher Scientific in Q4 2019 and has held it in 25 quarters since.
  • Veracity Capital's Thermo Fisher Scientific position peaked at $1.22M in Q3 2021.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Veracity Capital's 13F filing for Q3 2026, filed 8 Oct 2026.